Status:
COMPLETED
Ex Vivo Evaluation of the Interest of the Association of Platinum With a Molecule BH3-mimetic ABT-737 in Samples of Ovarian Tumors
Lead Sponsor:
Centre Francois Baclesse
Collaborating Sponsors:
GRECAN
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
The aim of the study is to quantify the ex vivo induction of apoptosis by ABT-737 + association platinum in samples exposed and demonstrate the value of this combination compared to the agents used al...
Eligibility Criteria
Inclusion
- Patient aged over 18 years
- Ovarian cancer patients with at least five tumor samples does not affect the diagnosis, based on other tumor masses
- Surgery of any initial chemotherapy naive
- Patient information and signed informed consent
Exclusion
- A person deprived of liberty or under guardianship
- Insufficient tumor samples of ovarian cancer.
Key Trial Info
Start Date :
April 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT01440504
Start Date
April 1 2010
End Date
January 1 2013
Last Update
February 7 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre François Baclesse
Caen, France, 14076